IP Library › Assignment 058547/0932
Patent Assignment
Reel/Frame 058547/0932

Assignment of Assignor's Interest

Recorded: 2022-01-05 Pages: 6
Assignor
QUARK PHARMACEUTICALS, INC.
Executed: 2021-12-23
Assignee
ONCOMATRYX BIOPHARMA, S.L.
801-B PARQUE TECNOLOGICO DE BIZKAIA, DERIO, BIZKAIA, 48160, SPAIN
Covered Properties (2)
Composition of Anti-ENDO180 Antibodies and Methods of Use for the Treatment of Cancer and Fibrotic Diseases
Patent: 8,444,983 →
Application: 13/255,214 →
Publication: US 2012/0114704
Composition of Anti-ENDO180 Antibodies and Methods of Use for the Treatment of Cancer and Fibrotic Diseases
Patent: 9,993,567 →
Application: 14/795,429 →
Publication: US 2015/0359905
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 8, 2011
From: FEINSTEIN, ELENA
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 026873/0815 →
Patent Security Agreement Jun 11, 2012
From: QUARK PHARMACEUTICALS, INC.; Q.B.I. ENTERPRISES LTD.
To: NITTO DENKO CORPORATION
Reel/Frame 028357/0123 →
Release of Security Interest in Patents Oct 17, 2013
From: NITTO DENKO CORPORATION
To: QUARK PHARMACEUTICALS, INC.; Q.B.I. ENTERPRISES LTD.
Reel/Frame 031434/0671 →